Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-30 Åä 00:36
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 1,281°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
DAPT+NOAC, ÃâÇ÷À§ÇèÀº ¾î¼³ª?
DAPT+NOAC → 3Á¦º´¿ë½É¹æ¼¼µ¿¿¡ ÀÇÇÑ ³úÁ¹Áß À§ÇèÀ» ÁÙÀ̱â À§ÇØ °æ±¸Ç×ÀÀ°íÁ¦ Ä¡·á¸¦ ¹Þ°í Àִ ȯÀÚ°¡ Çù½ÉÁõÀ̳ª ½É±Ù°æ...
ÀÌ»óµ· ±âÀÚ
|
2023-07-05 15:31
¶óÀÎ
[Drug Review]
PAD Àç°ü·ù¼ú ÈÄ ¡®»ç¸£Æ÷±×·¼·¹ÀÌÆ® + ¾Æ½ºÇǸ°¡¯ DAPT ±Ù°Å È®º¸
»ç¸£Æ÷±×·¼·¹ÀÌÆ®»ç¸£Æ÷±×·¼·¹ÀÌÆ®´Â ¼±ÅÃÀû ¼¼·ÎÅä´Ñ(5-HT 2A)¼ö¿ëü ±æÇ×Á¦·Î, ¼¼·ÎÅä´Ñ¿¡ ÀÇÇÑ Ç÷°ü ¼öÃà°ú Ç÷¼ÒÆÇ ÀÀÁýÀ» ¾ïÁ¦ÇÑ´Ù. ...
ÀÓ¼¼Çü ±âÀÚ
|
2023-07-05 15:26
¶óÀÎ
[Expert Opinion]
ARB + ÀÌ´¢Á¦ ÀÓ»ó Àû¿ëÀü·« :
·Î»ç¸£Åº + Ŭ·Î¸£Å»¸®µ·À» Áß½ÉÀ¸·Î
°íÇ÷¾ÐÀº ½ÉÇ÷°üÁúȯÀÇ ÁÖ¿ä À§ÇèÀÎÀÚÀÌÀÚ ´ëÇ¥ÀûÀÎ ¸¸¼ºÁúȯÀÌ´Ù. ´ëÇÑ°íÇ÷¾ÐÇÐȸ Korea Hypertension Fact Sheet 20...
THE MOST
|
2023-07-05 15:11
¶óÀÎ
[Late Breaking Studies]
Ŭ·ÎÇǵµ±×·¼ ´ë»ç´É·Â Àå±â°£ ½ÉÇ÷°ü ¾Æ¿ôÄÄ¿¡ ¿µÇâ
PTRG-DES ¿¬±¸ ȯÀÚ±ºÀÌ ¿¬±¸´Â PTRG-DES ÄÁ¼Ò½Ã¾ö¿¡ µî·ÏµÈ ȯÀÚµéÀ» ´ë»óÀ¸·Î Çß´Ù. PTRG-DES ÄÁ¼Ò½Ã¾ö¿¡´Â ±¹³» 32...
ÀÓ¼¼Çü ±âÀÚ
|
2023-07-05 15:00
¶óÀÎ
[Interview]
Çѱ¹ÀÎ ACS ȯÀÚ, ¸ÂÃãÇü DAPT Àü·« ÇÊ¿äÇÏ´Ù
±¹³» Ç×Ç÷Àü¿ä¹ýÀÇ Àû¿ë ÇöȲÀº?¼Û¿µºó Ç×Ç÷Àü¿ä¹ýÀº Çù½ÉÁõ, ½É±Ù°æ»öÁõ, ½É¹æ¼¼µ¿, °æÇÇÀû°ü»óµ¿¸ÆÁßÀç¼ú(PCI) ȯÀÚ¿¡¼ Æø³Ð°Ô Àû¿ëµÈ´Ù...
ÀÓ¼¼Çü ±âÀÚ
|
2023-07-05 14:54
¶óÀÎ
[Expert Opinion]
±¹³» ´ç´¢º´ Ä¡·á½ÃÀåÀÇ º¯È¿Í DPP-4i/SGLT-2iÀÇ ÀÓ»óÀû¿ë
Ç÷´ç°ÇÏÁ¦ º´¿ëó¹æ°ú º¸Çè±Þ¿©DPP-4¾ïÁ¦Á¦(DPP-4i)¿Í SGLT-2¾ïÁ¦Á¦(SGLT-2i) º´¿ë°ú °ü·ÃÇØ º¸Çè±Þ¿©°¡ È®´ëµÊ¿¡ µû¶ó,...
THE MOST
|
2023-07-05 14:45
¶óÀÎ
[Conference Report]
±¹³» ȯÀÚ ´ë»ó MET + DPP-4i + SGLT-2i º´¿ë¿ä¹ý ±Ù°Å Á¦½Ã
SOLUTION 2- ¸ÞÆ®Æ÷¸£¹Î ±â¹Ý DPP-4i + SGLT-2i Ãß°¡ SOLUTION 2 ¿¬±¸¿¡¼´Â ¸ÞÆ®Æ÷¸£¹Î ´Üµ¶¿ä...
ÀÓ¼¼Çü ±âÀÚ
|
2023-07-05 14:31
¶óÀÎ
[Conference Report]
ÆéŸÀÌµå ±â¹Ý Ä¡·áÁ¦ °æÀï ´õ Ä¡¿ÇØÁø´Ù
·¹Å¸Æ®·çŸÀ̵å 2»óÀÓ»ó- GIP/GLP-1/GCGR »ïÁß ÀÛ¿ëÁ¦GIP/GLP-1/GCGR »ïÁß ÀÛ¿ëÁ¦ÀÎ ·¹Å¸Æ®·çŸÀ̵å´Â 2°³ÀÇ 2»óÀÓ»ó...
ÀÓ¼¼Çü ±âÀÚ
|
2023-07-05 14:28
¶óÀÎ
[Conference Report]
ReDM SEOUL 2023 SYMPOSIUM
"ÇÑ ¹ß ºü¸¥ ¼±º°°Ë»ç¿Í Àû±ØÀû º´¿ë¿ä¹ý °Á¶"- Àü¼÷ °æÈñÀÇ´ë ±³¼ö °æÈñÀÇ´ë Àü¼÷ ±³¼ö(°æÈñ´ëº´¿ø ³»ºÐºñ³»°ú)´Â °¿¬¿¡...
ÀÓ¼¼Çü ±âÀÚ
|
2023-07-03 16:17
¶óÀÎ
[Cover Story]
´ëÇÑ´ç´¢º´ÇÐȸ ¡®2023 ´ç´¢º´ Áø·áÁöħ¡¯ ÁýÁߺм®
1. ¾à¹°¼±ÅÃÀÇ ±âÁØÀº ¹«¾ùÀΰ¡?ÀÌ Áú¹®¿¡ ´ëÇÑ Áø·áÁöħ ±Ç°í¾ÈÀÇ ´äº¯À» º¸¸é, 2Çü´ç´¢º´ Ä¡·á¿¡ ÀÖ¾î Ç÷´ç°ÇÏÁ¦ ¼±ÅÃÀÇ ·Îµå¸ÊÀ» ´Ü¹ø...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 15:27
¶óÀÎ
[Deep in Guideline]
¡°½ÉºÎÀü µ¿¹Ý½Ã A1C ¹«°üÇÏ°Ô SGLT-2i ¿ì¼±¡±
2Çü´ç´¢º´ ¾à¹°Ä¡·áÇмú´ëȸ ÇöÀå¿¡¼ ÀÎÁ¦ÀÇ´ë ³ëÁ¤Çö ±³¼ö(ÀÏ»ê¹éº´¿ø ³»ºÐºñ³»°ú)´Â Áø·áÁöħÀÇ ¾à¹°Ä¡·á ±Ç°í¾È°ú °ü·ÃÇØ º¯°æµÈ ³»¿ë°ú ±Ù...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 15:20
¶óÀÎ
[Sub Story]
½ÉÀ塤½ÅÀåÁúȯ À§Çè°¨¼Ò, Ä¡·á¸ñÇ¥·Î Á¦½Ã
Ä¡·á¸ñÇ¥¿ÃÇØ °¡À̵å¶óÀÎÀÇ ¾à¹°Ä¡·á ¾Ë°í¸®µëÀº ¾à¹°Ä¡·á ¼±Åÿ¡¼ Å©°Ô µÎ °¥·¡ÀÇ Ä¡·á¸ñÇ¥¸¦ Á¦½ÃÇÏ°í ÀÖ´Ù. ¡â½ÉÀ塤½ÅÀåÁúȯ À§Çè°¨¼Ò¿Í ¡â...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 15:13
¶óÀÎ
[Interview]
Æø³ÐÀº 2Çü´ç´¢º´ ȯÀÚ¿¡¼ ÇýÅà ±â´ë
´ç´¢º´ °ü¸®¿¡¼ Ç÷´ç»Ó¸¸ ¾Æ´Ï¶ó Á׻󵿸ưæȼº ½ÉÇ÷°üÁúȯ(ASCVD), ½ÉºÎÀü, ¸¸¼º½ÅÀåÁúȯ(CKD)¿¡ ´ëÇÑ ºñÁßµµ Ä¿Áö¸é¼ ´ç´¢º´ Ä¡...
ÀÓ¼¼Çü ±âÀÚ
|
2023-06-05 14:51
¶óÀÎ
[Sub Story]
´ÙÆı۸®Ç÷ÎÁø ½ÉºÎÀü Àü¹æÀ§ Ä¿¹ö´É·Â ÀÎÁ¤¹Þ¾Æ
HFmrEF¡¤HFpEFDELIVER ¿¬±¸¿¡¼´Â Á½ɽǹÚÃâ·üÀÌ 40% ÀÌ»óÀÎ ½ÉºÎÀü ȯÀÚ 6263¸íÀ» ¸ðÁýÇØ ´ÙÆı۸®Ç÷ÎÁø±º°ú À§¾à±ºÀ¸·Î...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 14:43
¶óÀÎ
[Interview]
¡°SGLT-2i/TZD, ´Ù¸¥ ±âÀüÀÇ Á¶ÇÕÀ¸·Î ½Ã³ÊÁö È¿°ú ±â´ë¡±
´ç´¢º´ °ü¸®Àü·«¿¡¼ ÀûÀýÇÑ ¾à¹°¼±ÅÃÀÇ Á߿伺ÀÌ ´õ¿í °Á¶µÇ°í ÀÖ´Ù. ´ëÇÑ´ç´¢º´ÇÐȸÀÇ Diabetes Fact Sheet in Korea...
ÀÓ¼¼Çü ±âÀÚ
|
2023-06-05 14:18
¶óÀÎ
[Sub Story]
Ç÷´çº¯µ¿¼º¡¤ÀúÇ÷´çÁõ, Ç÷°üÇÕº´Áõ ¿¹¹æ À§ÇÑ Ä¡·áŸ±ê
Ç÷°üÇÕº´Áõ À§ÇèÀÇ Ç¥ÁöÀÚ´çÈÇ÷»ö¼Ò(A1C), °øº¹Ç÷´ç(FPG), ½ÄÈÄÇ÷´ç(PPG)¿¡ ´õÇØ Ç÷´çº¯µ¿¼ºÀ» ´ç´¢º´ Ä¡·áÀÇ »õ·Î¿î Ÿ±êÀ¸·Î »ï...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 13:59
¶óÀÎ
[Sub Story]
Ç÷´çº¯µ¿¼ºÀº °³¼±
üÁß¡¤½ÉÇ÷°ü¡¤ÀúÇ÷´ç¿¡´Â Á߸³
Ç÷´çº¯µ¿¼º¡¤ÀúÇ÷´çÁõDPP-4¾ïÁ¦Á¦´Â ÀÎÅ©·¹Æ¾À» ºñÈ°¼ºÈÇÏ´Â DPP-4 È¿¼Ò¸¦ ¾ïÁ¦ÇØ GLP-1ÀÇ »ýÈ°¼ºÈ¸¦ ÃËÁøÇÏ´Â ±âÀüÀÌ´Ù. ü³» Ç÷...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 13:47
¶óÀÎ
[Sub Story]
¼³Æù¿ä¼ÒÁ¦, ½Å¼Ó¡¤°·Â Ç÷´ç°ÇÏ ¿©ÀüÈ÷ °Á¡
½Å¼ÓÇÑ °·Â Ç÷´ç°ÇÏÀÓ»ó¿¡¼ ´ç´¢º´ °ü·Ã ·¹°Å½ÃÀÌÆåÆ®¸¦ ½ÇÇöÇÏ·Á¸é ÃʱâÄ¡·á ´Ü°è¿¡¼ ´Ü±â°£¿¡ °·ÂÇÑ Ç÷´ç°Çϸ¦ À¯µµÇÒ ¼ö ÀÖ´Â Ç÷´ç°ÇÏÁ¦°¡ ÇÊ¿äÇÏ´Ù. Àü¹®°¡µéÀº ÀÌ°°Àº ¿ä±¸¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â °è¿·Î ¼³Æù¿ä¼ÒÁ¦¸¦ ²Å...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 13:32
¶óÀÎ
[Sub Story]
Ç÷´çÁ¶Àý¿¡¼ ½É³úÇ÷°üÁúȯ¡¤NAFLD±îÁö
PROactive ÇÇ¿À±Û¸®Å¸Á¸ÀÇ ½ÉÇ÷°ü ÇýÅÃÀ» ½Ã»çÇÑ »ç·Ê´Â PROactive(Lancet. 2005) ¿¬±¸°¡ ´ëÇ¥ÀûÀÌ´Ù...
ÀÓ¼¼Çü ±âÀÚ
|
2023-06-05 13:24
¶óÀÎ
[Interview]
´ç´¢º´ ȯÀÚÀÇ ³úÁ¹Áß °ü¸® À§ÇÑ È¿À²Àû ¹æ¾È
´ç´¢º´ Ä¡·áÀÇ Æз¯´ÙÀÓÀÌ Ç÷´ç°ÇÏ ¹× ½ÉÇ÷°üÁúȯ °ü¸®·Î Á¤ÂøµÇ°í ÀÖ´Ù. ¿ÃÇØ ¹Ì±¹´ç´¢º´ÇÐȸ(ADA) °¡À̵å¶óÀο¡¼´Â 2Çü´ç´¢º´ ȯÀÚÀÇ ...
ÀÓ¼¼Çü ±âÀÚ
|
2023-06-05 13:16
-
1
2
3
4
5
6
7
8
9
10
´ÙÀ½
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top